Article Archive
Aptivus achieves SVR in treatment-experienced children
18 August 2008
Heat-stable Norvir tablet is equivalent to capsule
18 August 2008
GSK's Epzicom comparable to Truvada
18 August 2008
Argos advances HIV immunotherapy approach
18 August 2008
Reyataz comparable to lopinavir in both genders
18 August 2008
76% of TMC278 patients achieve undetectable HIV
18 August 2008
Isentress works well in untreated HIV patients
18 August 2008
Kaletra works equally well in different patient groups
18 August 2008
After database review, GSK says D:A:D study "inconclusive"
18 August 2008
Nutra Pharma unit renews CDC contract
18 August 2008
Odyssey Thera gets Pfizer milestone
18 August 2008
Law suits stall awaiting FDA pre-emption verdict
18 August 2008
Genetix' first-half 2008 revenues up 19%
18 August 2008
Evotec's first-half 2008 revenue falls 8%
18 August 2008
Acambis narrows first-half 2008 loss 37%
18 August 2008
deCODE's 2nd-qtr 2008 net loss widens 13.6%
18 August 2008
Richter's first-half profit down 29%
11 August 2008
Sequenom expands deal with SensiGen
11 August 2008
Danone's Souvenaid benefits mild AD patients
11 August 2008
AB42 in CSF strongly correlates with amyloid in brain
11 August 2008
Celgene returns satraplatin rights to GPC
11 August 2008
Alkermes/J&J's Vivitrol approved in Russia
11 August 2008
Covance signs R&D accord with Eli Lilly
11 August 2008
Noven gets final $25M Shire milestone
11 August 2008
Kowa acquires ProEthic Pharma
11 August 2008
Randall Moreadith joins Nektar to head drug development
11 August 2008
Bayer names Greg Babe as new US CEO
11 August 2008
Senior promotions at ImmunoGen
11 August 2008
Oscient promotes Mark Glickman
11 August 2008
Diatos' cancer drug enters Ph II trials
11 August 2008
Biota's novel antiviral "indistinguishable" from oseltamivir
11 August 2008
Harvard to integrate IP with Oxford Nanopore
11 August 2008
InterMed's novel Hif-1 cancer drug shows proof-of-principle
11 August 2008
ChanTest debuts new business for cell lines
11 August 2008
Octapharma to acquire 33 US plasma centers
11 August 2008
Vivus announces $65 million offering
11 August 2008
1.1B US doctor visits in 2006, 2.6B drugs Rxed
11 August 2008
African drug tariffs hamper AIDS efforts
11 August 2008
Vyteris to pursue joint developments in pain mangement
11 August 2008
Stock Commentary - Europe - week to Aug 4, 2008
11 August 2008
Stock Commentary - New York week to Aug 4, 2008
11 August 2008
UK cancer charity slams NICE methods
11 August 2008
35 US states have govt-run Rx database
11 August 2008
US court ruling leaves drug compounding in confusion
11 August 2008
Ph III salmon calcitonin trial completes recruitment
11 August 2008
Isolagen sees Ph III efficacy for wrinkle treatment
11 August 2008
IVT secures key US patent
11 August 2008
China opens door on SFDA's workings
11 August 2008
XTl Biopharm and Presidio amend license deal
11 August 2008
Pharmacopeia cuts workforce 40%
11 August 2008
Regeneron in VelociGene deal with Sanofi
11 August 2008
Nabi settles arbitration with Inhibitex
11 August 2008
GSK to decide soon on Exelixis drug option
11 August 2008
Speedel board backs Novartis offer
11 August 2008
Beximco's first-half pretax profit falls 26%
11 August 2008
Tracleer approved in EU for PAH FC II
11 August 2008
Ranbaxy's 2nd-qtr 2008 sales rise 13% to $432M
11 August 2008
Sun's 1st-qtr FY 2008 sales rise 66% to $246M
11 August 2008
Dr Reddy's 1st-qtr FY 2009 profit drops 26%
11 August 2008
Evotec/Pfizer's VR1 blocker enters Ph I testing
11 August 2008
Javelin expands Dyloject deal with Baxter
11 August 2008
2008/9 flu vaccines approved by US FDA
11 August 2008
Cosmo granted key US MMX patent
11 August 2008
Sanofi Pasteur starts shipping flu vaccine for 2008/9 season
11 August 2008
ALF launches bomb attack in France
11 August 2008
Satraplatin European MAA withdrawn
11 August 2008
Ofatumumab sees positive Ph III CLL data
11 August 2008
Japan stock market week to August 4, 2008
11 August 2008
US groups support Rx drug abuse campaign
11 August 2008
Novartis simplifies Rx access and management programs in USA
11 August 2008
Intellego expands expertise with Zenosis acquisition
11 August 2008
MorphoSys' first-half profit doubles on accord
11 August 2008
Bayer's 2nd-qtr 2008 net profit falls 13%
11 August 2008
Strong euro pushes drug prices up in UAE
11 August 2008
Australia PBS drug access not yet assured
11 August 2008
S-P's acadesine mimics exercise benefits in mice
11 August 2008
Japanese doctors do not trust generics
11 August 2008
S-P's boceprevir shows 74% SVR in HCV
11 August 2008
Belgium's new R&D tax incentive welcomed
11 August 2008
Pharmacopeia receives milestone from Wyeth
11 August 2008
Protagen closes financing for UNIarray
11 August 2008
FDA approves generic Depakote
11 August 2008
Evotec trial to be conducted by Pfizer
11 August 2008
Substandard HIV/AIDS drugs' resistance threat
11 August 2008
Indian firms worried over US Ranbaxy case
11 August 2008
ImClone chairman Icahn say B-MS offer undervalues the firm
11 August 2008
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
